BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Alternative Splicing of Breast Cancer Associated Gene BRCA1 from Breast Cancer Cell Line

  • Lixia, Miao (China Center for Type Culture Collection, Wuhan University) ;
  • Zhijian, Cao (State Key Laboratory of Virology, College of Life Sciences, Wuhan University) ;
  • Chao, Shen (China Center for Type Culture Collection, Wuhan University) ;
  • Chaojiang, Gu (China Center for Type Culture Collection, Wuhan University) ;
  • Congyi, Zheng (China Center for Type Culture Collection, Wuhan University)
  • Published : 2007.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Breast cancer is the most common malignancy among women, and mutations in the BRCA1 gene produce increased susceptibility to these malignancies in certain families. In this study, the forward 1-13 exons of breast cancer associated gene BRCA1 were cloned from breast cancer cell line ZR-75-30 by RT-PCR method. Sequence analysis showed that nine BRCA1 splice forms were isolated and characterized, compared with wild-type BRCA1 gene, five splice forms of which were novel. These splice isoforms were produced from the molecular mechanism of 5' and 3' alternative splicing. All these splice forms deleting exon 11b and the locations of alternative splicing were focused on two parts:one was exons 2 and 3, and the other was exons 9 and 10. These splice forms accorded with GT-AG rule. Most these BRCA1 splice variants still kept the original reading frame. Western blot analysis indicated that some BRCA1 splice variants were expressed in ZR-75-30 cell line at the protein level. In addition, we confirmed the presence of these new transcripts of BRCA1 gene in MDA-MB-435S, K562, Hela, HLA, HIC, H9, Jurkat and human fetus samples by RT-PCR analysis. These results suggested that breast cancer associated gene BRCA1 may have unexpectedly a large number of splice variants. We hypothesized that alternative splicing of BRCA1 possibly plays a major role in the tumorigenesis of breast and/or ovarian cancer. Thus, the identification of cancer-specific splice forms will provide a novel source for the discovery of diagnostic or prognostic biomarkers and tumor antigens suitable as targets for therapeutic intervention.

Keywords

References

  1. Au, W. W. and Henderson, B. R. (2005) The BRCA1 RING and BRCT domains cooperate in targeting BRCA1 to ionizing radiation-induced nuclear foci. J. Biol. Chem. 280, 6993-7001. https://doi.org/10.1074/jbc.M408879200
  2. Black, D. L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336. https://doi.org/10.1146/annurev.biochem.72.121801.161720
  3. Chambon, M., Nirde, P., Gleizes, M., Roger, P. and Vignon, F. (2003) Localization of BRCA1 protein in human breast cancer cells. Breast Cancer. Res. Treat. 79, 107-119. https://doi.org/10.1023/A:1023382223768
  4. Chen, Y., Chen, C. F., Riley, D. J., Allred, D. C., Chen, P. L., Von Hoff, D., Osborne, C. K. and Lee, W. H. (1995) Aberrant subcellular localization of BRCA1 in breast cancer. Science 270, 789-791. https://doi.org/10.1126/science.270.5237.789
  5. ElShamy, W. M. and Livingston, D. M. (2004) Identification of BRCA1-IRIS, a BRCA1 locus product. Nat. Cell Biol. 6, 954-967. https://doi.org/10.1038/ncb1171
  6. Faustino, N. A. and Cooper, T. A. (2003) Pre-mRNA splicing and human disease. Genes. Dev. 17, 419-437. https://doi.org/10.1101/gad.1048803
  7. Fortin, J., Moisan, A. M., Dumont, M., Leblanc, G., Labrie, Y., Durocher, F., Bessette, P., Bridge, P., Chiquette, J., Laframboise, R., Lepine, J., Lesperance, B., Pichette, R., Plante, M., Provencher, L., Voyer, P. and Simard, J. (2005) A new alternative splice variant of BRCA1 containing an additional in-frame exon. Biochim. Biophys. Acta. 1731, 57-65. https://doi.org/10.1016/j.bbaexp.2005.08.011
  8. Garcia-Blanco, M. A., Baraniak, A. P. and Lasda, E. L. (2004) Alternative splicing in disease and therapy. Nat. Biotechnol. 22, 535-546. https://doi.org/10.1038/nbt964
  9. Graveley, B. R. (2001) Alternative splicing: increasing diversity in the proteomic world. Trends. Genet. 17, 100-107. https://doi.org/10.1016/S0168-9525(00)02176-4
  10. Kalnina, Z., Zayakin, P., Silina, K. and Line, A. (2005) Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 42, 342-357. https://doi.org/10.1002/gcc.20156
  11. King, M. C., Marks, J. H. and Mandell, J. B. (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302, 643-646. https://doi.org/10.1126/science.1088759
  12. Lane, T. F. (2004) BRCA1 and transcription. Cancer Biol. Ther. 3, 528-533. https://doi.org/10.4161/cbt.3.6.843
  13. Lopez, A. J. (1998) Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu. Rev. Genet. 32, 279-305. https://doi.org/10.1146/annurev.genet.32.1.279
  14. Lu, M., Conzen, S. D., Cole, C. N. and Arrick, B. A. (1996) Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells. Cancer. Res. 56, 4578-4581.
  15. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W. and et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71. https://doi.org/10.1126/science.7545954
  16. Orban, T. I. and Olah, E. (2001) Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines. Biochem. Biophys. Res. Commun. 280, 32-38. https://doi.org/10.1006/bbrc.2000.4068
  17. Orban, T. I. and Olah, E. (2003) Emerging roles of BRCA1 alternative splicing. Mol. Pathol. 56, 191-197. https://doi.org/10.1136/mp.56.4.191
  18. Quinn, J. E., Kennedy, R. D., Mullan, P. B., Gilmore, P. M., Carty, M., Johnston, P. G. and Harkin, D. P. (2003) BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. Cancer Res. 63, 6221-6228.
  19. Scully, R., Ganesan, S., Brown, M., De Caprio, J. A., Cannistra, S. A., Feunteun, J., Schnitt, S. and Livingston, D. M. (1996) Location of BRCA1 in human breast and ovarian cancer cells. Science 272, 123-126. https://doi.org/10.1126/science.272.5258.123
  20. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck- Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T., Jammulapati, S., Janecki, T., Jiang, P., Kehrer, R., Leblanc, J. F., Mitchell, J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M., Snyder, S. C., Steele, L., Stringfellow, M., Stroup, C., Swedlund, B., Swense, J., Teng, D., Thomas, A., Tran, T., Tranchant, M., Weaver- Feldhaus, J., Wong, A. K., Shizuya, H., Eyfjord, J. E., Cannon- Albright, L., Tranchant, M., Labrie, F., Skolnick, M. H., Weber, B., Kamb, A. and Goldgar, D. E. (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12, 333-337. https://doi.org/10.1038/ng0396-333
  21. Thangaraju, M., Kaufmann, S. H. and Couch, F. J. (2000) BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J. Biol. Chem. 275, 33487-33496. https://doi.org/10.1074/jbc.M005824200
  22. Venkitaraman, A. R. (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-182. https://doi.org/10.1016/S0092-8674(02)00615-3
  23. Wilson, C. A., Payton, M. N., Elliott, G. S., Buaas, F. W., Cajulis, E. E., Grosshans, D., Ramos, L., Reese, D. M., Slamon, D. J. and Calzone, F. J. (1997) Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene 14, 1-16. https://doi.org/10.1038/sj.onc.1200924
  24. Wilson, C. A., Ramos, L., Villasenor, M. R., Anders, K. H., Press, M. F., Clarke, K., Karlan, B., Chen, J. J., Scully, R., Livingston, D., Zuch, R. H., Kanter, M. H., Cohen, S., Calzone, F. J. and Slamon, D. J. (1999) Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Genet. 21, 236-240. https://doi.org/10.1038/6029
  25. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C. and Micklem, G. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792. https://doi.org/10.1038/378789a0

Cited by

  1. BRCA1exon 11 alternative splicing, multiple functions and the association with cancer vol.40, pp.4, 2012, https://doi.org/10.1042/BST20120140
  2. BRCA1 Exon 11, a CERES (Composite Regulatory Element of Splicing) Element Involved in Splice Regulation vol.15, pp.7, 2014, https://doi.org/10.3390/ijms150713045
  3. The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells vol.11, pp.1, 2011, https://doi.org/10.1186/1475-2867-11-29
  4. Potential blood biomarkers for stroke vol.9, pp.4, 2012, https://doi.org/10.1586/epr.12.33
  5. Species-specific variation of RPA-interacting protein (RIP) splice isoforms vol.42, pp.1, 2009, https://doi.org/10.5483/BMBRep.2009.42.1.022
  6. Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium vol.23, pp.14, 2014, https://doi.org/10.1093/hmg/ddu075
  7. Differential expression of parental alleles of BRCA1 in human preimplantation embryos vol.25, pp.1, 2016, https://doi.org/10.1038/ejhg.2016.121
  8. Identification of a novel mutations BRCA1*c.80 + 3del4 and BRCA2*c.6589delA in Slovak HBOC families vol.119, pp.1, 2010, https://doi.org/10.1007/s10549-008-0244-6
  9. Cloning and functional identification of two novel BRCA1 splicing variants vol.73, pp.11, 2008, https://doi.org/10.1134/S0006297908110072
  10. Deregulation of splicing factors and breast cancer development vol.7, pp.5, 2015, https://doi.org/10.1093/jmcb/mjv027
  11. Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer vol.7, pp.Suppl 5, 2013, https://doi.org/10.1186/1752-0509-7-S5-S8
  12. PEPPI: a peptidomic database of human protein isoforms for proteomics experiments vol.11, pp.S6, 2010, https://doi.org/10.1186/1471-2105-11-S6-S7